Specialization
Hospital Pharmacy
Focus of research
Pharmacology of CFTR modulators in Cystic Fibrosis
-
Correlation between trough concentration and AUC for elexacaftor, tezacaftor and ivacaftor
Vonk, S. E. M., Altenburg, J., Mathôt, R. A. A. & Amsterdam Mucociliary Clearance Disease (AMCD) research group, 2024, (E-pub ahead of print) In: Journal of cystic fibrosis.Research output: Contribution to journal › Article › Academic › peer-review
-
Stepwise Introduction of Elexacaftor-Tezacaftor-Ivacaftor in Patients With Cystic Fibrosis and Liver Cirrhosis Child-Pugh A or B Using Clinical and Therapeutic Drug Monitoring: A Case Series
Vonk, S. E. M., Lub, R., Weersink, E. J. M. & Amsterdam mucociliary clearance disease research group, 2023, (E-pub ahead of print) In: Clinical therapeutics.Research output: Contribution to journal › Article › Academic › peer-review
-
Real-life efficacy and safety of elexacaftor/tezacaftor/ivacaftor on severe cystic fibrosis lung disease patients
Amsterdam Mucociliary Clearance Disease (AMCD) research group, 1 Dec 2022, In: Pharmacology research & perspectives. 10, 6, p. e01015 e01015.Research output: Contribution to journal › Article › Academic › peer-review
- All publications